Status:

ACTIVE_NOT_RECRUITING

Aerobic Exercise and Cerebrovascular Function

Lead Sponsor:

VA Office of Research and Development

Conditions:

Aging

Eligibility:

All Genders

65-80 years

Phase:

PHASE2

PHASE3

Brief Summary

This proposal will evaluate two brain health measures, cerebrovascular perfusion and cerebrovascular reactivity (CVR), before and after a proven, interval-based, aerobic exercise intervention in older...

Detailed Description

To address the growing healthcare challenges of an aging Veteran population it is critical to understand effective rehabilitation techniques that mitigate age-related co-morbidity and improve quality ...

Eligibility Criteria

Inclusion

  • Adults aged 65-80 who do not regularly exercise
  • defined as exercising less than 20 minutes twice per week
  • Are willing and able to cooperate with assessments and interventions
  • Participant will be quantified at or below the "poor" range for cardiovascular fitness as assessed by a volume of oxygen (VO2) test
  • 0 ml/kg/min for males
  • 0 ml/kg/min for females)
  • 26 on the MoCA to meet the criteria for cognitively intact
  • Participants will be free from diseases affecting cognition or that would interfere with their ability to engage in aerobic exercise - including but not limited to:
  • chronic heart
  • liver
  • kidney disease
  • Free from diseases/injuries directly affecting brain functions - including but not limited to:
  • significant closed head injury
  • open intracranial wounds
  • stroke
  • epilepsy
  • degenerative diseases of the nervous system
  • All subjects will speak English as a primary language and will have at minimum a high school diploma so that behavioral/cognitive measures reflect effects of aging and aerobic exercise and not unfamiliarity with the English language or a lack of education

Exclusion

  • Potential participants with major psychiatric disorder - including but not limited to:
  • psychosis
  • major depression
  • bipolar disorder
  • Individuals with ongoing drug or alcohol abuse and severe hypertension (systolic BP \> 200 or diastolic BP \> 110 mm Hg or subjects taking three or more antihypertensive medications
  • Participants must not have conditions incompatible with MRI - including but not limited to:
  • ferrous metal implants
  • cardiac pacemakers or similar devices
  • claustrophobia
  • morbid obesity
  • Persons engaging in significant skilled manual movements regularly will be excluded so that behavioral/motor measures reflect the effects of age and aerobic exercise and not the effects of frequent practice

Key Trial Info

Start Date :

April 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03803904

Start Date

April 1 2019

End Date

May 1 2026

Last Update

May 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, United States, 30033-4004